Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
MOORE CAPITAL MANAGEMENT LP | 02-14-2024 | 12-31-2023 | 422 | 5,804,006,073 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
AMYLYX PHARMACEUTICALS INC | COM | Liquidated | $0 | 0 | 0.00 | 47,078 | +Inf | 12-31-2023 | |
TRANSUNION | COM | 1402 | $831,254 | 12,098 | 0.00 | 12,098 | +Inf | 12-31-2023 | |
TWELVE SEAS INVESTMENT CO II | COM CL A | 1403 | $792,000 | 75,000 | 0.00 | 0.00 | -25,000 | -25.00 | 12-31-2023 |
JAZZ PHARMACEUTICALS PLC | SHS USD | Liquidated | $0 | 0 | 0.00 | 0.00 | -5,900 | -49.17 | 12-31-2023 |